Melanie Ashton
Melanie Ashton
Verified email at deakin.edu.au
Title
Cited by
Cited by
Year
Staging in bipolar disorder: from theoretical framework to clinical utility
M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, AF Carvalho, ...
World Psychiatry 16 (3), 236-244, 2017
832017
Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial
OM Dean, B Kanchanatawan, M Ashton, M Mohebbi, CH Ng, M Maes, ...
Australian & New Zealand Journal of Psychiatry 51 (8), 829-840, 2017
442017
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial
OM Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, ...
Clinical Psychopharmacology and Neuroscience 12 (3), 180, 2014
382014
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 72, 73-86, 2017
272017
Mitochondrial agents for bipolar disorder
C Pereira, V Chavarria, J Vian, MM Ashton, M Berk, W Marx, OM Dean
International journal of neuropsychopharmacology 21 (6), 550-569, 2018
132018
The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia
MM Ashton, OM Dean, AJ Walker, CC Bortolasci, CH Ng, M Hopwood, ...
Frontiers in psychiatry 10, 115, 2019
52019
Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial
MM Ashton, M Berk, CH Ng, M Hopwood, S Dodd, A Turner, E Brown, ...
Brazilian Journal of Psychiatry 41 (3), 245-253, 2019
32019
Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial
BE Kavanagh, LJ Williams, M Berk, A Turner, HJ Jackson, M Mohebbi, ...
Brazilian Journal of Psychiatry 42 (1), 14-21, 2020
22020
Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis
BE Kavanagh, SL Brennan-Olsen, A Turner, OM Dean, M Berk, ...
BMJ open 9 (4), e025145, 2019
22019
Protocol and rationale: A 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostana linn.(Mangosteen) pericarp for schizophrenia
A Turner, JJ McGrath, OM Dean, S Dodd, A Baker, SM Cotton, JG Scott, ...
Clinical Psychopharmacology and Neuroscience 17 (2), 297, 2019
22019
Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review
MM Ashton, M Berk, CH Ng, M Hopwood, B Kavanagh, LJ Williams, ...
BMJ open 9 (4), e025640, 2019
12019
The efficacy of adjunctive Garcinia Mangostana Linn pericarp for bipolar depression: a 24-week double-blind, randomised, placebo controlled trial
M Ashton, M Berk, C Ng, M Hopwood, B Harvey, O Dean
Proceedings of the 18th Annual Conference of the International Society for …, 2016
12016
Left global visual hemineglect in high Autism-spectrum Quotient (AQ) individuals
D Crewther, D Crewther, M Ashton, A Kuang
Journal of Vision 10 (7), 358-358, 2010
12010
Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials
W Marx, A Scholey, J Firth, NM D’Cunha, M Lane, M Hockey, MM Ashton, ...
Neuroscience & Biobehavioral Reviews, 2020
2020
Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial
MM Ashton, M Mohebbi, A Turner, W Marx, M Berk, GS Malhi, CH Ng, ...
The Canadian Journal of Psychiatry 65 (5), 306-318, 2020
2020
Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with …
MM Ashton, OM Dean, W Marx, M Mohebbi, M Berk, GS Malhi, CH Ng, ...
Australian & New Zealand Journal of Psychiatry 54 (2), 159-172, 2020
2020
Physical activity as a predictor of treatment outcomes for bipolar depression
MM Ashton, M Berk, CH Ng, M Hopwood, M Mohebbi, OM Dean
BIPOLAR DISORDERS 21, 135-135, 2019
2019
Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial.
BE Kavanagh, LJ Williams, M Berk, A Turner, HJ Jackson, M Mohebbi, ...
A| A 1 (2), 3, 2019
2019
Diet quality, dietary inflammatory index and body composition as predictors of N-acetylcysteine and mitochondrial agents efficacy in bipolar disorder
M Ashton, OM Dean, W Marx, M Mohebi, M Berk, GS Malhi, C Ng, ...
European Neuropsychopharmacology 29, S64-S65, 2019
2019
Mitochondrial modifying nutrients in treating chronic fatigue syndrome: A 16-week open-label pilot study
R Menon, L Cribb, J Murphy, MM Ashton, G Oliver, N Dowling, A Turner, ...
Advances in integrative medicine 4 (3), 109-114, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20